BICYCLIC HETEROARYL COMPOUNDS AS PDE10 INHIBITORS

The invention pertains to tricyclic heteraaryi compounds that serve as effective phosphodiesterase (PDE) inhibitors. The invention also relates to compounds which are selective inhibitors of PDE 10. The invention further relates to pharmaceutical compositions comprising such compounds; and the use o...

Full description

Saved in:
Bibliographic Details
Main Authors VERHOEST, PATRICK ROBERT, HOOVER, DENNIS JAY
Format Patent
LanguageEnglish
French
Published 23.04.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention pertains to tricyclic heteraaryi compounds that serve as effective phosphodiesterase (PDE) inhibitors. The invention also relates to compounds which are selective inhibitors of PDE 10. The invention further relates to pharmaceutical compositions comprising such compounds; and the use of such compounds in methods for treating certain central nervous system (CNS) or other disorders. The invention relates also to methods for treating neurodegenerative and psychiatric disorders, for example psychosis and disorders comprising deficient cognition as a symptom. L'invention concerne des composés d'hétéroaryle bicyclique servant d'inhibiteurs efficaces de la phosphodiestérase (PDE). L'invention concerne également des composés qui sont des inhibiteurs sélectifs de la PDE 10. L'invention concerne également des compositions pharmaceutiques comprenant ces composés et l'utilisation de ces composés dans des méthodes destinées au traitement de certains troubles du système nerveux central (SNC) et d'autres troubles. L'invention concerne également des méthodes destinées au traitement de troubles neurodégénératifs et psychiatriques, tels que la psychose et des troubles ayant comme symptôme un déficit de la cognition.
Bibliography:Application Number: WO2007IB01129